Pembrolizumab Combined With GDP Regimen Inducing Sustained Remission in Histiocytic Sarcoma: A Case Report

• Hauptverfasser: Jinjie Gao MD (Verfasst von), Min Li MD (Verfasst von), Cuiling Liu MD (Verfasst von), Hongmei Jing MD (Verfasst von)
• Format: Buch
• Veröffentlicht: SAGE Publishing, 2024-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm with an aggressive clinical course and a poor response to conventional chemotherapy. Currently, no standard treatment paradigms are available. Herein, we present a case of de novo HS treated with pembrolizumab combined with a GDP regimen (gem...